7,686
Views
80
CrossRef citations to date
0
Altmetric
Review Articles

Healthcare-associated viral and bacterial infections in dentistry

, , , , &
Article: 17659 | Received 28 Feb 2012, Accepted 11 May 2012, Published online: 12 Jun 2012

References

  • Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Francois G, et al.. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004; 80: 185–91. 10.3402/jom.v4i0.17659.
  • Karjala Z, Neal D, Rohrer J. Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007–2008. PLoS One. 2011; 6: e19092. 10.3402/jom.v4i0.17659.
  • Lin H, He N, Su M, Feng J, Chen L, Gao M. Herpes simplex virus infections among rural residents in eastern China. BMC Infect Dis. 2011; 11: 69. 10.3402/jom.v4i0.17659.
  • Wheeler CE, Jr. The herpes simplex problem. J Am Acad Dermatol. 1988; 18: 163–8. 10.3402/jom.v4i0.17659.
  • Kameyama T, Sujaku C, Yamamoto S, Hwang CB, Shillitoe EJ. Shedding of herpes simplex virus type 1 into saliva. J Oral Pathol. 1988; 17: 478–81. 10.3402/jom.v4i0.17659.
  • Hanley PJ, Conaway MM, Halstead DC, Rhodes LV, III, Reed J, III. Nosocomial herpes simplex virus infection associated with oral endotracheal intubation. Am J Infect Control. 1993; 21: 310–6. 10.3402/jom.v4i0.17659.
  • Spruance SL. Herpes simplex labialis. Clinical management of herpes viruses. Sacks SL, Straus SE, Whiteley RJ, Griffiths PDIOS Press. Amsterdam, 1995; 3–42.
  • Browning WD, Mccarthy JP. A case series: herpes simplex virus as an occupational hazard. J Esthet Restor Dent. 2012; 24: 61–6. 10.3402/jom.v4i0.17659.
  • Rowe NH, Heine CS, Kowalski CJ. Herpetic whitlow: an occupational disease of practicing dentists. J Am Dent Assoc. 1982; 105: 471–3.
  • Manzella JP, Mcconville JH, Valenti W, Menegus MA, Swierkosz EM, Arens M. An outbreak of herpes simplex virus type I gingivostomatitis in a dental hygiene practice. JAMA. 1984; 252: 2019–22. 10.3402/jom.v4i0.17659.
  • Wolleswinkel-Van Den Bosch JH, Speets AM, Rumke HC, Gumbs PD, Fortanier SC. The burden of varicella from a parent's perspective and its societal impact in the Netherlands: an Internet survey. BMC Infect Dis. 2011; 11: 320. 10.3402/jom.v4i0.17659.
  • Gnann JW, Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002; 347: 340–6. 10.3402/jom.v4i0.17659.
  • Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010; 48((Suppl 1)): S2–7. 10.3402/jom.v4i0.17659.
  • Langley JM, Hanakowski M. Variation in risk for nosocomial chickenpox after inadvertent exposure. J Hosp Infect. 2000; 44: 224–6. 10.3402/jom.v4i0.17659.
  • Yoshikawa T, Ihira M, Suzuki K, Suga S, Tomitaka A, Ueda H, et al.. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol. 2001; 63: 64–6. 10.3402/jom.v4i0.17659.
  • Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis. 2004; 189: 1009–12. 10.3402/jom.v4i0.17659.
  • Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med. 1997; 102: 9–15. 10.3402/jom.v4i0.17659.
  • Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE, et al.. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med. 1990; 113: 740–6.
  • Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian multicenter study. The Italian Study group on occupational risk of HIV infection. Arch Intern Med. 1993; 153: 1451–8. 10.3402/jom.v4i0.17659.
  • Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al.. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for disease control and prevention needlestick surveillance group. N Engl J Med. 1997; 337: 1485–90. 10.3402/jom.v4i0.17659.
  • Shugars DC, Wahl SM. The role of the oral environment in HIV-1 transmission. J Am Dent Assoc. 1998; 129: 851–8.
  • Health Protection Agency. Occupational transmission of HIV. Summary of published reports. March 2005 edition. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947320156.
  • Ciesielski C, Marianos D, Ou CY, Dumbaugh R, Witte J, Berkelman R, et al.. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med. 1992; 116: 798–805.
  • Astagneau P, Lot F, Bouvet E, Lebascle K, Baffoy N, Aggoune M, et al.. Lookback investigation of patients potentially exposed to HIV type 1 after a nurse-to-patient transmission. Am J Infect Control. 2002; 30: 242–5. 10.3402/jom.v4i0.17659.
  • Lot F, Seguier JC, Fegueux S, Astagneau P, Simon P, Aggoune M, et al.. Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med. 1999; 130: 1–6.
  • Bosch X. Second case of doctor-to-patient HIV transmission. Lancet Infect Dis. 2003; 3: 261. 10.3402/jom.v4i0.17659.
  • Mccarthy GM, Sali CS, Bednarsh H, Jorge J, Wangrangsimakul K, Page-Shafer K. Transmission of HIV in the dental clinic and elsewhere. Oral Dis. 2002; 8((Suppl 2)): 126–35. 10.3402/jom.v4i0.17659.
  • Health Protection Agency. Occupational transmission of HIV: summary of published reports. March 2005 edition. Data to the end of December 2002. Health Protection Agency Centre for Infections and Collaborators; 2005. Available from http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947320156.
  • Margolis HS, Alter MJ, Hadler SC. Viral hepatitis. Viral infections of humansfourth ed. Evans AS, Kaslow RAPlenum Medical Books Co. New York, 1997; 363–418.
  • Hadler SC, Doto IL, Maynard JE, Smith J, Clark B, Mosley J, et al.. Occupational risk of hepatitis B infection in hospital workers. Infect Control. 1985; 6: 24–31.
  • Cleveland JL, Siew C, Lockwood SA, Gruninger SE, Gooch BF, Shapiro CN. Hepatitis B vaccination and infection among US dentists, 1983–1992. J Am Dent Assoc. 1996; 127: 1385–90.
  • Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis. 1994; 170: 1410–7. 10.3402/jom.v4i0.17659.
  • Werner BG, Grady GF. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med. 1982; 97: 367–9.
  • US Public Health Service. Updated US public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001; 50: 1–52.
  • Lauer JL, Vandrunen NA, Washburn JW, Balfour HH, Jr. Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis. 1979; 140: 513–6. 10.3402/jom.v4i0.17659.
  • Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet. 1981; 1: 550–1. 10.3402/jom.v4i0.17659.
  • Perry JL, Pearson RD, Jagger J. Infected health care workers and patient safety: a double standard. Am J Infect Control. 2006; 34: 313–9. 10.3402/jom.v4i0.17659.
  • Redd JT, Baumbach J, Kohn W, Nainan O, Khristova M, Williams I. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis. 2007; 195: 1311–4. 10.3402/jom.v4i0.17659.
  • Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008; 48: 148–62. 10.3402/jom.v4i0.17659.
  • Bellentani S, Miglioli L, Masutti F, Saccoccio G, Tiribelli C. Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery. Microbes Infect. 2000; 2: 1757–63. 10.3402/jom.v4i0.17659.
  • Naoumov NV. Hepatitis C virus infection in Eastern Europe. J Hepatol. 1999; 31((Suppl 1)): 84–7. 10.3402/jom.v4i0.17659.
  • Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al.. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011; 31((Suppl 2)): 61–80. 10.3402/jom.v4i0.17659.
  • Jagger J, Puro V, De Carli G. Occupational transmission of hepatitis C virus. JAMA. 2002; 288: 1469; author reply1469–71.
  • Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, et al.. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis. 2005; 41: 1423–30. 10.3402/jom.v4i0.17659.
  • Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet. 1991; 338: 1539–42. 10.3402/jom.v4i0.17659.
  • Weegink CJ, Sentjens RE, Van Der Heyden JF, Chamuleau RA, Tytgat GN, Beld MG. A physician with a positive hepatitis C virus RNA test after a needlestick injury. Eur J Gastroenterol Hepatol. 2003; 15: 1367–9. 10.3402/jom.v4i0.17659.
  • Berger CM, Leentvaar-Kuijpers A, Van Doornum GJ, Coutinho RA. Accidentele blootstelling aan bloed en risico op transmissie van virusinfecties bij verschillende beroepsgroepen in Amsterdam, 1986–1996. Ned Tijdschr Geneeskd 1998. . 142: 2312–4.
  • Lodi G, Porter SR, Teo CG, Scully C. Prevalence of HCV infection in health care workers of a UK dental hospital. Br Dent J. 1997; 183: 329–32. 10.3402/jom.v4i0.17659.
  • Porter S, Scully C, Samaranayake L. Viral hepatitis. Current concepts for dental practice. Oral Surg Oral Med Oral Pathol. 1994; 78: 682–95. 10.3402/jom.v4i0.17659.
  • Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011; 378: 57–72. 10.3402/jom.v4i0.17659.
  • Abubakar I, Lipman M, Anderson C, Davies P, Zumla A. Tuberculosis in the UK – time to regain control. BMJ. 2011; 343: 10.3402/jom.v4i0.17659.
  • Carvalho AC, Migliori GB, Cirillo DM. Tuberculosis in Europe: a problem of drug resistance or much more?. Expert Rev Respir Med. 2010; 4: 189–200. 10.3402/jom.v4i0.17659.
  • Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med. 2001; 345: 189–200. 10.3402/jom.v4i0.17659.
  • Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev. 2012; 36: 514–32. 10.3402/jom.v4i0.17659.
  • Barry CE, III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009; 7: 845–55.
  • Cleveland JL, Gooch BF, Bolyard EA, Simone PM, Mullan RJ, Marianos DW. TB infection control recommendations from the CDC, 1994: considerations for dentistry. United States Centers for Disease Control and Prevention. J Am Dent Assoc. 1995; 126: 593–9.
  • Cleveland JL, Robison VA, Panlilio AL. Tuberculosis epidemiology, diagnosis and infection control recommendations for dental settings: an update on the Centers for disease control and prevention guidelines. J Am Dent Assoc. 2009; 140: 1092–9.
  • Smith WH, Davies D, Mason KD, Onions JP. Intraoral and pulmonary tuberculosis following dental treatment. Lancet. 1982; 1: 842–4. 10.3402/jom.v4i0.17659.
  • Cleveland JL, Kent J, Gooch BF, Valway SE, Marianos DW, Butler WR, et al.. Multidrug-resistant Mycobacterium tuberculosis in an HIV dental clinic. Infect Control Hosp Epidemiol. 1995; 16: 7–11. 10.3402/jom.v4i0.17659.
  • Harlow RF, Rutkauskas JS. Tuberculosis risk in the hospital dental practice. Spec Care Dentist. 1995; 15: 50–5. 10.3402/jom.v4i0.17659.
  • Cadmus SI, Okoje VN, Taiwo BO, Van Soolingen D. Exposure of dentists to Mycobacterium tuberculosis, Ibadan, Nigeria. Emerg Infect Dis. 2010; 16: 1479–81. 10.3402/jom.v4i0.17659.
  • Fujitani S, Sun HY, Yu VL, Weingarten JA. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest. 2011; 139: 909–19. 10.3402/jom.v4i0.17659.
  • Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol. 2011; 12: 157–69. 10.3402/jom.v4i0.17659.
  • Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health. 2009; 2: 101–11. 10.3402/jom.v4i0.17659.
  • Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect (Larchmt). 2009; 10: 389–97. 10.3402/jom.v4i0.17659.
  • Willcox MD. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci. 2007; 84: 273–8. 10.3402/jom.v4i0.17659.
  • Van Delden C. Pseudomonas aeruginosa bloodstream infections: how should we treat them?. Int J Antimicrob Agents. 2007; 30((Suppl 1)): S71–5. 10.3402/jom.v4i0.17659.
  • Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res. 2010; 10: 441–51. 10.3402/jom.v4i0.17659.
  • Barbeau J, Tanguay R, Faucher E, Avezard C, Trudel L, Cote L, et al.. Multiparametric analysis of waterline contamination in dental units. Appl Environ Microbiol. 1996; 62: 3954–9.
  • Barben J, Kuehni CE, Schmid J. Water quality in dental chair units. A random sample in the canton of St. Gallen. Schweiz Monatsschr Zahnmed. 2009; 119: 976–85.
  • Jensen ET, Giwercman B, Ojeniyi B, Bangsborg JM, Hansen A, Koch C, et al.. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J Hosp Infect. 1997; 36: 117–22. 10.3402/jom.v4i0.17659.
  • Martin MV. The significance of the bacterial contamination of dental unit water systems. Br Dent J. 1987; 163: 152–4. 10.3402/jom.v4i0.17659.
  • Scannapieco FA, Ho AW, Ditolla M, Chen C, Dentino AR. Exposure to the dental environment and prevalence of respiratory illness in dental student populations. J Can Dent Assoc. 2004; 70: 170–4.
  • Pankhurst CL, Coulter W, Philpott-Howard JN, Surman-Lee S, Warburton F, Challacombe S. Evaluation of the potential risk of occupational asthma in dentists exposed to contaminated dental unit waterlines. Prim Dent Care. 2005; 12: 53–9. 10.3402/jom.v4i0.17659.
  • Putnins EE, Di Giovanni D, Bhullar AS. Dental unit waterline contamination and its possible implications during periodontal surgery. J Periodontol. 2001; 72: 393–400. 10.3402/jom.v4i0.17659.
  • Newton HJ, Ang DK, Van Driel IR, Hartland EL. Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev. 2010; 23: 274–98. 10.3402/jom.v4i0.17659.
  • Gomez-Valero L, Rusniok C, Buchrieser C. Legionella pneumophila: population genetics, phylogeny and genomics. Infect Genet Evol. 2009; 9: 727–39. 10.3402/jom.v4i0.17659.
  • Wadowsky RM, Wolford R, Mcnamara AM, Yee RB. Effect of temperature, pH, and oxygen level on the multiplication of naturally occurring Legionella pneumophila in potable water. Appl Environ Microbiol. 1985; 49: 1197–205.
  • Sabria M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis. 2002; 2: 368–73. 10.3402/jom.v4i0.17659.
  • Pankhurst CL, Coulter WA. Do contaminated dental unit waterlines pose a risk of infection?. J Dent. 2007; 35: 712–20. 10.3402/jom.v4i0.17659.
  • Atlas RM, Williams JF, Huntington MK. Legionella contamination of dental-unit waters. Appl Environ Microbiol. 1995; 61: 1208–13.
  • Challacombe SJ, Fernandes LL. Detecting Legionella pneumophila in water systems: a comparison of various dental units. J Am Dent Assoc. 1995; 126: 603–8.
  • Walker JT, Bradshaw DJ, Bennett AM, Fulford MR, Martin MV, Marsh PD. Microbial biofilm formation and contamination of dental-unit water systems in general dental practice. Appl Environ Microbiol. 2000; 66: 3363–7. 10.3402/jom.v4i0.17659.
  • Veronesi L, Capobianco E, Affanni P, Pizzi S, Vitali P, Tanzi ML. Legionella contamination in the water system of hospital dental settings. Acta Biomed. 2007; 78: 117–22.
  • Pankhurst CL, Coulter W, Philpott-Howard JJ, Harrison T, Warburton F, Platt S, et al. Prevalence of legionella waterline contamination and Legionella pneumophila antibodies in general dental practitioners in London and rural Northern Ireland. Br Dent J. 2003; 195: 591–4.; discussion 58110.3402/jom.v4i0.17659.
  • Pankhurst CL. Risk assessment of dental unit waterline contamination. Prim Dent Care. 2003; 10: 5–10. 10.3402/jom.v4i0.17659.
  • Ricci ML, Fontana S, Pinci F, Fiumana E, Pedna MF, Farolfi P, et al.. Pneumonia associated with a dental unit waterline. Lancet. 2012; 379: 684. 10.3402/jom.v4i0.17659.
  • Fotos PG, Westfall HN, Snyder IS, Miller RW, Mutchler BM. Prevalence of Legionella-specific IgG and IgM antibody in a dental clinic population. J Dent Res. 1985; 64: 1382–5. 10.3402/jom.v4i0.17659.
  • Reinthaler FF, Mascher F, Stunzner D. Serological examinations for antibodies against Legionella species in dental personnel. J Dent Res. 1988; 67: 942–3. 10.3402/jom.v4i0.17659.
  • European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).Stockholm: ECDC; 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/1111_SUR_AMR_data.pdf.pdf.
  • Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002; 136: 834–44.
  • Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y, the CNSE Working Group. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15(46): pii = 19711. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId = 19711.
  • Wieler LH, Ewers C, Guenther S, Walther B, Lubke-Becker A. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol. 2011; 301: 635–41. 10.3402/jom.v4i0.17659.
  • Smith AJ, Robertson D, Tang MK, Jackson MS, Mackenzie D, Bagg J. Staphylococcus aureus in the oral cavity: a three-year retrospective analysis of clinical laboratory data. Br Dent J. 2003; 195: 701–3.; discussion 694. 10.3402/jom.v4i0.17659.
  • O'Leary E, Lockhart DE, Smith A. Coming to a practice near you? Community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA). Dent Update 2011; 38: 254–6, 259–60..
  • Parton M, Beasley NJ, Harvey G, Houghton D, Jones AS. Four cases of aggressive MRSA wound infection following head and neck surgery. J Laryngol Otol. 1997; 111: 874–6. 10.3402/jom.v4i0.17659.
  • Mitchell TE, Pickles JM. Four cases of aggressive MRSA wound infection following head and neck surgery. J Laryngol Otol. 1998; 112: 422.
  • Supriya M, Shakeel M, Santangeli L, Ah-See KW. Controlling MRSA in head and neck cancer patients: what works?. Otolaryngol Head Neck Surg. 2009; 140: 224–7. 10.3402/jom.v4i0.17659.
  • Smith AJ, Jackson MS, Bagg J. The ecology of Staphylococcus species in the oral cavity. J Med Microbiol. 2001; 50: 940–6.
  • Kock R, Becker K, Cookson B, Van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al.. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. 2010; 15: 19688.
  • Petti S, Polimeni A. Risk of methicillin-resistant staphylococcus aureus transmission in the dental healthcare setting: a narrative review. Infect Control Hosp Epidemiol. 2011; 32: 1109–15. 10.3402/jom.v4i0.17659.
  • Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA?. Lancet Infect Dis. 2008; 8: 289–301. 10.3402/jom.v4i0.17659.
  • Reddy Y. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) nazal colonization among dental professionals (MPH thesis). Ann Arbor. MI: ProQuest. 2010.
  • Gorwitz RJ, Kruszon-Moran D, Mcallister SK, Mcquillan G, Mcdougal LK, Fosheim GE, et al.. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis. 2008; 197: 1226–34. 10.3402/jom.v4i0.17659.
  • Roberts MC, Soge OO, Horst JA, Ly KA, Milgrom P. Methicillin-resistant Staphylococcus aureus from dental school clinic surfaces and students. Am J Infect Control. 2011; 39: 628–32. 10.3402/jom.v4i0.17659.
  • Martin MV, Hardy P. Two cases of oral infection by methicillin-resistant Staphylococcus aureus. Br Dent J. 1991; 170: 63–4. 10.3402/jom.v4i0.17659.
  • Kurita H, Kurashina K, Honda T. Nosocomial transmission of methicillin-resistant Staphylococcus aureus via the surfaces of the dental operatory. Br Dent J. 2006; 201: 297–300.; discussion 291. 10.3402/jom.v4i0.17659.
  • Motta RH, Groppo FC, Bergamaschi C, de C, Ramacciato JC, Baglie S, De Mattos-Filho TR. Isolation and antimicrobial resistance of staphylococcus aureus isolates in a dental clinic environment. Infect Control Hosp Epidemiol. 2007; 28: 185–90. 10.3402/jom.v4i0.17659.
  • Westergard EJ, Romito LM, Kowolik MJ, Palenik CJ. Controlling bacterial contamination of dental impression guns. J Am Dent Assoc. 2011; 142: 1269–74.
  • Egusa H, Watamoto T, Abe K, Kobayashi M, Kaneda Y, Ashida S, et al.. An analysis of the persistent presence of opportunistic pathogens on patient-derived dental impressions and gypsum casts. Int J Prosthodont. 2008; 21: 62–8.
  • Grover SS, Sharma M, Pasha ST, Singh G, Lal S. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi. J Commun Dis. 2004; 36: 17–26.
  • Mobbs KJ, Van Saene HK, Sunderland D, Davies PD. Oropharyngeal Gram-negative bacillary carriage: a survey of 120 healthy individuals. Chest. 1999; 115: 1570–5. 10.3402/jom.v4i0.17659.
  • Mehra P, Murad H. Maxillary sinus disease of odontogenic origin. Otolaryngol Clin North Am. 2004; 37: 347–64. 10.3402/jom.v4i0.17659.
  • March A, Aschbacher R, Dhanji H, Livermore DM, Bottcher A, Sleghel F, et al.. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect. 2010; 16: 934–44.
  • Murk JL, Heddema ER, Hess DL, Bogaards JA, Vandenbroucke-Grauls CM, Debets-Ossenkopp YJ. Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units. J Clin Microbiol. 2009; 47: 1885–7. 10.3402/jom.v4i0.17659.
  • Roshan M, Ikram A, Mirza IA, Malik N, Abbasi SA, Alizai SA. Susceptibility pattern of extended spectrum ß-lactamase producing isolates in various clinical specimens. J Coll Physicians Surg Pak. 2011; 21: 342–6.
  • Doebbeling BN, Vaughn TE, McCoy KD, Beekmann SE, Woolson RF, Ferguson KJ, et al.. Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk?. Clin Infect Dis. 2003; 37: 1006–13. 10.3402/jom.v4i0.17659.
  • Molinari JA. Infection control: its evolution to the current standard precautions. J Am Dent Assoc. 2003; 134: 569–74.; quiz 631–2.